Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) is the first ETF in the world focused on this exciting area of healthcare
The dual receptor activity means that tirzepatide at a theoretically "equivalent" dose may feel significantly stronger
Continuous outcomes were analyzed using ANCOVA, with randomized treatment as a factor and baseline body weight as a covariate, while categorical data were analyzed with binary logistic regression
Vomiting was reported by 24% of the patients, diarrhea by 30%, constipation 24%, abdominal pain 20%, headache 14%, fatigue (tiredness) 11%, indigestion 9%, dizziness 8%, abdominal bloating 7%, flatulence 6%, loud burping 7%, low blood sugar (hypoglycemia) 6% and other side effects
A colleague in the newsroom said the name yesterday, and even though I hadnt thought about it in decades, the smell instantly came back to me